11/15/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:43 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:16 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
6:19 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:27 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/23/2024
3:07 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:15 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/27/2024
3:15 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:01 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:55 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:40 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form S-3ASR | |
09/10/2024
3:04 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:06 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:06 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:12 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:13 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:19 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
4:15 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:32 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:13 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:38 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:52 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
6:27 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:31 PM | Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:31 PM | Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:33 PM | Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:34 PM | Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:34 PM | Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:14 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump said you could learn something from this man (Ad) Early Warning: A Deep Crack Is Forming In The US Economy
Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.  Here’s everything you need to know. |
06/17/2024
7:49 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/10/2024
6:13 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:48 PM | Centessa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/13/2024
3:32 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:00 AM | Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |
05/09/2024
7:01 AM | Centessa Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
7:53 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/24/2024
8:26 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
4:16 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/22/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:17 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:16 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:44 PM | Centessa Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:16 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:06 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:37 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
6:12 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:10 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:02 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:03 PM | Centessa Pharmaceuticals (Issuer)
Rotman Harris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:04 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:07 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:08 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:09 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
6:41 PM | Centessa Pharmaceuticals (Issuer)
GRAINGER DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:43 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:44 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:45 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:46 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:37 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:05 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CNTA Stock Alerts